Pay in 4 interest-free payments of $2.50 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Collaborations could lead to AI-driven features on the Masa platform
Their eco-friendly focus meets rising consumer and regulatory needs
driven by London and Tokyo matching engines
Accelerated Sales Cycles
$860M revenue mix
PHARMEASY PORTER'S FIVE FORCES TEMPLATE RESEARCH B_189 Collaborations could lead to AI-drivenA Must Have Tool for Decision Makers PharmEasy faces intense buyer pressure, margin squeezing competition, and regulatory headwinds that shape its growth trajectory; this snapshot highlights key tensions but omits force by force scoring and scenario analysis. Suppliers Bargaining Power Pharmaceutical Manufacturer Dominance Large pharma firms like Sun Pharma and Cipla wield high supplier power because branded drugs responsible for ~45% of Indian
US$ 79.99
US$ 115.20
US$ 244.50
US$ 25.00
US$ 27.50
US$ 89.95
US$ 16.00
US$ 182.72
US$ 137.19
![Bulbasaur - Pokemon 151 [ART RARE]](https://www.pokeninjapan.store/cdn/shop/files/166165bulbasaur-ar-japanese-pokemon-single-card151-sv2a-9955730.jpg?v=1772743334)
